Sodium Acetate → 5-(4-chlorophenyl)-5-(3-{4-[1-(3,3-difluoropyrrolidin-1-yl)ethyl]piperidin-1-yl}-3-oxopropyl)-5H-imidazo[2,1-a]isoindole

HRID 46174Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 46174
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2([CH2:20][CH2:21][C:22]([N:24]3[CH2:29][CH2:28][CH:27]([C:30](=O)[CH3:31])[CH2:26][CH2:25]3)=[O:23])[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:10]3=[N:17][CH:18]=[CH:19][N:9]23)=[CH:4][CH:3]=1.[Cl-].[F:34][C:35]1([F:40])[CH2:39][CH2:38][NH2+:37][CH2:36]1.CC([O-])=O.[Na+].[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+]>C(Cl)Cl.CC(O)=O>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2([CH2:20][CH2:21][C:22]([N:24]3[CH2:25][CH2:26][CH:27]([CH:30]([N:37]4[CH2:38][CH2:39][C:35]([F:40])([F:34])[CH2:36]4)[CH3:31])[CH2:28][CH2:29]3)=[O:23])[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:10]3=[N:17][CH:18]=[CH:19][N:9]23)=[CH:6][CH:7]=1

Komponenten

7

Edukt 4

HCID 517045Sodium AcetateHCID 27828263,3-Difluoropyrrolidine, chlorideHCID 5049666Sodium triacetoxyborohydrideHCID 58415640HCID 58415640, Verbindung

Produkt 1

HCID 566664195-(4-chlorophenyl)-5-(3-{4-[1-(3,3-difluoropyrrolidin-1-yl)ethyl]piperidin-1-yl}-3-oxopropyl)-5H-imidazo[2,1-a]isoindole

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 176Acetic AcidLösungsmittelHCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

To a mixture of 1-(1-{3-[5-(4-chlorophenyl)-5H-imidazo[2,1-a]isoindol-5-yl]propanoyl}piperidin-4-yl)ethanone (27 mg), 3,3-difluoropyrrolidinium chloride (17 mg) and NaOAc (15 mg) in CH2Cl2 was added AcOH (0.01 mL). After stirring the resulting mixture for 30 minutes NaBH(OAc)3 (26 mg) was added and allowed to stir overnight. The reaction mixture was then partitioned between saturated aqueous NaHCO3 and CH2Cl2. Aqueous layer was extracted with CH2Cl2 (2×). Combined organic layers were dried over Na2SO4 and concentrated. Purification by reversed phase HPLC (21×100 mm Phenomenex Gemini, 15-95% MeCN/water containing 0.05% NH4OH over 20 min at 20 mL/min) afforded title compound as a white solid. HRMS. Found, 539.2387; calcd for (M+H)+, 539.2384. 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J=7.62 Hz, 1 H); 7.43-7.38 (m, 1 H); 7.35-7.26 (m, 4 H); 7.25-7.19 (m, 1 H); 7.11 (d, J=8.36 Hz, 2 H); 6.96 (d, J=9.03 Hz, 1 H); 4.54 (d, J=13.34 Hz, 1 H); 3.31 (d, J=13.41 Hz, 1 H); 3.11-3.03 (m, 1 H); 2.91-2.80 (m, 3 H); 2.76-2.61 (m, 3 H); 2.38-2.13 (m, 4 H); 1.69-1.50 (m, 6 H); 0.90-0.83 (m, 4 H).

Aufarbeitung

  1. additionwas added
  2. customThe reaction mixture was then partitioned between saturated aqueous NaHCO3 and CH2Cl2
  3. extractionAqueous layer was extracted with CH2Cl2 (2×)
  4. dry with materialCombined organic layers were dried over Na2SO4
  5. concentrationconcentrated
  6. customPurification by reversed phase HPLC (21×100 mm Phenomenex Gemini, 15-95% MeCN/water containing 0.05% NH4OH over 20 min at 20 mL/min)

Quellen und Nachweise

ORD-Eintrag
ord-cf58ac05f7324b8b80f17e90c1c31663
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08541595B2

Notizen zur Reaktion

Wird geladen…